InMed Pharmaceuticals (MWG.STU) Q2 2025 Earnings

13MayConfirmed
Q2 2025
-1.73
-1.4
-1.07
-0.73

Details

Expected EPS
N/A
Actual EPS
-1.7336422
Surprise EPS
-1.73
Surprise Percent
+∞%

Description

InMed Pharmaceuticals (MWG.STU) has reported earnings of -1.7336422 per share for Q2 2025.

0 Comments

Share your thoughts